about
Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in JapanHepatitis C Virus Impairs p53 via Persistent Overexpression of 3 -Hydroxysterol 24-ReductaseVariation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriersRadiofrequency ablation of hepatocellular carcinoma: Current statusNetwork fingerprint: a knowledge-based characterization of biomedical networks.Enhanced laser thermal ablation for the in vitro treatment of liver cancer by specific delivery of multiwalled carbon nanotubes functionalized with human serum albuminmicroRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection.Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C.Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values.Effect of laparoscopic splenectomy in patients with Hepatitis C and cirrhosis carrying IL28B minor genotype350-560 μm gelatin sponge particles combined with transcatheter arterial chemoembolization for the treatment of elderly hepatocellular carcinoma: The safety and efficacyHistory of blood transfusion before 1990 is associated with increased risk for cancer mortality independently of liver disease: a prospective long-term follow-up study.Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinomaDeclining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005.Sustained viral response of a case of acute hepatitis C virus infection via needle-stick injury.Data mining reveals complex interactions of risk factors and clinical feature profiling associated with the staging of non-hepatitis B virus/non-hepatitis C virus-related hepatocellular carcinoma.Helical tomotherapy for single and multiple liver tumoursTotal and high molecular weight adiponectin and hepatocellular carcinoma with HCV infection.Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.Antiviral treatment for hepatitis C virus infection after liver transplantation.Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.Epidemiology of primary and secondary liver cancers.Consumption of coffee associated with reduced risk of liver cancer: a meta-analysisAssociation of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection.Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinomaRETRACTED: Molecular epidemiology of a hepatitis C virus outbreak in a leprosy sanatorium in Japan.Oncogenic potential of hepatitis C virus proteinsTumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer.Serum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma.Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response.Clinical characteristics of hepatocellular carcinoma in elderly patients.Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free TreatmentSerum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in PatientsEctopic Hepatocellular Carcinoma Arising from the Peritoneum in a Patient with a History of Oropharyngeal Cancer: A Case Report.Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinomaPPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.Hepatocellular carcinoma: therapy and prevention.Predictive role of miR-146a rs2910164 (C>G), miR-149 rs2292832 (T>C), miR-196a2 rs11614913 (T>C) and miR-499 rs3746444 (T>C) in the development of hepatocellular carcinoma.The incidence of hepatocellular carcinoma associated with hepatitis C infection decreased in Kyushu areaImpairment of IFN-alpha production capacity in patients with hepatitis C virus and the risk of the development of hepatocellular carcinoma
P2860
Q27490399-3B7D70C3-A063-4CC9-93BE-D26AEA95D2C7Q27490516-F3BF2CDC-9928-477A-8D14-3A8802A7D304Q28943479-3E22D4F8-C9EB-45AC-BA18-815D3DA0B122Q30478030-2EA91AF4-D50E-458F-9462-852B42823932Q30662482-7136EFC3-0E57-4C03-9F27-3E8B4AD41CF5Q30997634-18B920FE-84F7-4A5E-91CD-8C3E958104A6Q31141908-C411EC13-6AC7-458D-928C-8328C6F0AE44Q33373813-940E846B-D388-4509-BF2F-F7757B569AFDQ33388299-DA5C2149-D4D4-47E5-A7CB-47DA846CF6DAQ33404324-9B54592D-BC6D-40FE-942C-428B17F222D5Q33606153-08621539-9BA8-4BA4-8F5B-FF136A0201C2Q33788274-00C7903B-103F-4A0D-8FB1-784EC4F20D23Q33797504-FB98BFEC-C342-499A-AFBE-635DA546374BQ33816094-0FCA60EA-BDAF-4E5B-A490-C0831765100DQ33867893-BC362D4C-7042-4B5C-9FE1-DCDB4FA44A11Q33875631-6548534C-F0D1-436A-8FC1-0468A13BB769Q33975859-C5CB4776-0D46-4CBA-912E-AD4BD4B752F2Q34081435-349442E1-5F40-4633-9B9F-9B2BDC770C56Q34112285-A0215E2A-B77E-447A-B144-BF32E5DE4343Q34340293-4B4538BF-A376-43A4-ABBF-0F5393BEA31BQ34416873-EC17AA17-751D-465A-B2CF-07BA9755EF2AQ34563350-DB389CD3-86A0-4C3A-82B2-0007513858B9Q34596852-2F922BA9-4C51-4E17-AFA1-BE40248F4C2AQ35085706-E8E86189-549B-4CE8-964D-5CCB6A66A6C2Q35142785-206F9956-1EFD-4427-A0BA-B5F4F59A9EE4Q35192347-332EC458-4FD7-4475-89C7-28FCF2755A74Q35261292-AC98A857-3969-410A-B292-E5C1F1630CFBQ35576670-C3294D93-3263-47EE-BB31-1A60695CE18AQ35606927-191552F2-B80D-4A0D-A2FD-62324BF5C126Q35662485-75D5886E-AB1D-420A-9A76-0CC1C3F12AD7Q36126670-DB16FFCD-CC54-495C-8FCF-8FF5F4193099Q36146807-579276D7-7ACB-42EA-9078-B49F67FC96D8Q36194266-60081B4C-4423-496C-B7A2-A106AFED7231Q36291697-1C4E44E0-1F50-44EA-963A-9446A0185336Q36303796-F9F90EB7-9F3C-4B16-8642-E36430E07F0DQ36330881-9BF672BC-66EC-481B-94BD-95D93E7F7183Q36377949-5E2457C1-D0C5-427F-AE36-37BBA7632171Q36464885-C341BE0E-0E93-4B04-8CEE-0494B8C37045Q36473813-D2161F1B-CEF8-4EFA-9EF7-B551938B0929Q36497089-438249AD-64F9-432F-9FB1-F454523281F4
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Hepatocellular carcinoma: recent trends in Japan.
@ast
Hepatocellular carcinoma: recent trends in Japan.
@en
type
label
Hepatocellular carcinoma: recent trends in Japan.
@ast
Hepatocellular carcinoma: recent trends in Japan.
@en
prefLabel
Hepatocellular carcinoma: recent trends in Japan.
@ast
Hepatocellular carcinoma: recent trends in Japan.
@en
P2093
P1433
P1476
Hepatocellular carcinoma: recent trends in Japan
@en
P2093
Akihiro Matsumoto
Eiji Tanaka
Kaname Yoshizawa
Kendo Kiyosawa
Tetsuya Ichijo
P304
P356
10.1053/J.GASTRO.2004.09.012
P407
P433
P577
2004-11-01T00:00:00Z